Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
cancer
4
×
cancer drugs
4
×
clinical trials
life sciences
national blog main
ipo
san francisco blog main
sanofi
fda
investing
national top stories
revolution medicines
san francisco
san francisco top stories
the column group
third rock ventures
warp drive bio
agios pharmaceuticals
amgen
black diamond therapeutics
bladder cancer
blueprint medicines
cobimetinib
colorectal cancer
david e. shaw
deals
deciphera pharmaceuticals
drug discovery
eli lilly
enasidenib
endometral cancer
europe blog main
european society for medical oncology
glioblastoma
ivosidenib
loxo oncology
mark goldsmith
What
ipo
4
×
medicines
4
×
cancer
research
drug
proteins
revolution
targets
biotech
black
cancer’s
clinic
companies
company’s
course
despite
development
diamond
discover
disease
eluded
experimental
family
frontiers
growing
handiwork
hardest
helped
hit
hopes
hottest
hunters
internal
known
landscape
lead
leading
lines
maps
molecular
Language
unset
Current search:
medicines
×
cancer
×
ipo
×
" cancer drugs "
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic